Faculty & Community
Insights into groundbreaking faculty research, innovative projects, and academic thought leadership across Harvard’s schools and institutes.
A New Narrative of Civil Rights
Political philosopher Brandon Terry’s vision of racial progress
Doing Community Medicine
A few years ago, instructor of medicine Pieter Cohen began noticing a strange pattern of symptoms among some of his Brazilian immigrant patients...
Shanghai Central
Harvard on July 1 opened the newest in an expanding network of international offices, in Shanghai, and is scheduled to launch another in Beijing...
A Startling Achievement in Regenerative Medicine
Douglas Melton, co-director of the Harvard Stem Cell Institute, has figured out how to transform one type of cell in a living animal into another, using...
A Startling Achievement in Regenerative Medicine
Douglas Melton, co-director of the Harvard Stem Cell Institute, has figured out how to transform one type of cell in a living animal into another, using a new process his research team has dubbed “direct reprogramming”...
Bearer of Bad News
Roubini's pessimistic prognostications have won such supporters as Cabot professor of public policy Kenneth S. Rogoff; Jeffrey Sachs ’76, Ph.D. ’81...
Eye on Iran and Israel
"This autumn may be Israel's last and best chance to go after Iran's nuclear capability," Feldman wrote in the New York Times Magazine recently...
A Call for Credit-Card Disclosure
Proposed amendments to the federal Truth in Lending regulations would be a welcome change, Richard Thaler and Cass R. Sunstein argued on the Wall Street Journal opinion page last week...
Scary Superbugs
The article documents how, and why, we are losing the war against these powerful microbes. Hospitals and doctors have overused "last-resort" antibiotics, leading to...
Harvard scientists create first disease-specific human stem cell lines
Kevin Eggan, an assistant professor of stem-cell and regenerative biology, announced in Science that he had used the technique to create...
XDR-TB Can Be Treated
More than 60 percent of HIV-negative XDR -TB patients in the study, which was conducted in home and community-based settings in Peru...